- Filed
- Mar 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 28, 2025 | 13.39M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2024 | $0 |
| Stock Repurchased | FY 2024 · Dec 31, 2023 | $0 |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $43.01M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $525.62M |
| Long Term Debt | FY 2024 · Jan 1, 2022 | $564.22M |
| Long Term Debt | FY 2024 · Dec 31, 2021 | $478.15M |
| Short Term Debt | FY 2024 · Dec 31, 2023 | $3.13M |
| Short Term Debt | FY 2024 · Jan 1, 2022 | $169.22M |
| Short Term Debt | FY 2024 · Dec 31, 2021 | $166.01M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $112.05M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $75.63M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $678.63M |
| Current Assets | FY 2024 · Dec 31, 2023 | $196.48M |
| Total Assets | FY 2024 · Dec 31, 2023 | $802.76M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 12.79M sh |
| Capex | FY 2024 · Dec 31, 2022 | $11.44M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $42.97M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$14.69 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$14.69 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $152.38M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $55.55M |
| Net Income | FY 2024 · Dec 31, 2022 | −$187.95M |
| Operating Income restated | FY 2024 · Dec 31, 2022 | −$32.76M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $368.94M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $57.77M |
| Revenue | FY 2024 · Dec 31, 2022 | $984.99M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $447.99M |